论文部分内容阅读
背景及目的 作者用辛酸钠纯化及柱层析法去除辛酸钠后制得一种新的静脉用免疫球蛋白(IGIV)制剂,并进行了有效的脂膜病毒灭活。作者设计2个临床试验以比较这种以甘氨酸作为保护剂的新制剂IGIV-C10％(Gamunex,10％)和溶剂洗涤
Background and purpose The authors prepared a new intravenous immunoglobulin (IGIV) preparation by sodium caprylate purification and column chromatography to remove sodium caprylate and performed effective inactivation of the lipid membrane virus. The authors designed two clinical trials to compare this new agent IGIV-C10% (Gamunex, 10%) with glycine as a protective agent and a solvent wash